Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer
about
Mechanisms of resistance to anti-EGFR therapy in colorectal cancerCoGAPS matrix factorization algorithm identifies transcriptional changes in AP-2alpha target genes in feedback from therapeutic inhibition of the EGFR network.Hypoxia Mediates Differential Response to Anti-EGFR Therapy in HNSCC CellsHow to Hit Mesenchymal Stromal Cells and Make the Tumor Microenvironment Immunostimulant Rather Than Immunosuppressive.Integrated time course omics analysis distinguishes immediate therapeutic response from acquired resistance.Lower gingival squamous cell carcinoma with brain metastasis during long-term cetuximab treatment: A case report.
P2860
Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cetuximab promotes epithelial ...... ents with head and neck cancer
@ast
Cetuximab promotes epithelial ...... ents with head and neck cancer
@en
type
label
Cetuximab promotes epithelial ...... ents with head and neck cancer
@ast
Cetuximab promotes epithelial ...... ents with head and neck cancer
@en
prefLabel
Cetuximab promotes epithelial ...... ents with head and neck cancer
@ast
Cetuximab promotes epithelial ...... ents with head and neck cancer
@en
P2093
P2860
P356
P1433
P1476
Cetuximab promotes epithelial ...... ents with head and neck cancer
@en
P2093
Bernhard Mlecnik
Gabriela Bindea
Jean-Pascal Machiels
Roxana Irina Albu
Sandra Schmitz
P2860
P304
34288-34299
P356
10.18632/ONCOTARGET.5924
P407
P577
2015-09-30T00:00:00Z